W. Anthony Vernon - May 16, 2022 Form 4/A - Amendment Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
W. Anthony Vernon, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/28/2022, 07:11 PM
Date Of Original Report
May 18, 2022
Previous filing
Apr 1, 2022
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +141K $0.00 141K May 16, 2022 Class A Common Stock 141K $4.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 16, 2023); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

Remarks:

This amendment is being filed solely to correct the number of shares covered by the stock option granted on May 16, 2022, which was erroneously reported in the original Form 4 due to an administrative error.